| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8709150 | Sleep Medicine | 2018 | 24 Pages |
Abstract
This study did not show significant benefit from a single 500Â mg FCM treatment for RLS symptoms. The two previous, well-controlled, trials of 1000Â mg FCM showed significant treatment benefits which suggested that there may have been a clinically relevant total dose required to achieve a clinical response.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Yong Won Cho, Richard P. Allen, Christopher J. Earley,